Amylyx Pharmaceuticals, Inc. (AMLX)
33.83
+0.08
(+0.24%)
USD |
NASDAQ |
Sep 01, 16:00
33.83
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Cash from Operations (Annual) : -123.34M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -123.34M |
| December 31, 2024 | -167.65M |
| December 31, 2023 | 11.92M |
| December 31, 2022 | -179.87M |
| Date | Value |
|---|---|
| December 31, 2021 | -74.80M |
| December 31, 2020 | -36.70M |
| December 31, 2019 | -10.69M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Pfizer Inc. | 11.70B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |
| EyePoint, Inc. | -240.11M |
| Bristol Myers Squibb Co. | 14.16B |